XXI Wealth LLC’s GSK GSK Stock Holding History

XXI Wealth LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$220K	Buy	+4,206	New	+$222K	0.1%	212

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XXI Wealth LLC's GSK Position: Q2 2026 in Review

XXI Wealth LLC opened a new position in GSK (GSK) in Q2 2026: 4,206 shares worth $220K. The stake represents 0.1% of the portfolio and ranks #212 among its holdings.

1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

XXI Wealth LLC held 4,206 shares of GSK worth $220K as of Q2 2026.
GSK was a new XXI Wealth LLC position in Q2 2026.
GSK made up 0.1% of XXI Wealth LLC's portfolio in Q2 2026, its #212 holding.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on XXI Wealth LLC's 13F filing for Q2 2026, filed 14 Aug 2026.